J Korean Neurol Assoc.  2016 Feb;34(1):77-79. 10.17340/jkna.2016.1.17.

Reduction of Disease Activity in Patient with Relapsing-Remitting Multiple Sclerosis after Switching to Teriflunomide from Interferon Beta

Affiliations
  • 1Department of Neurology, Yeungnam University College of Medicine, Daegu, Korea. minsupark@ynu.ac.kr

Abstract

No abstract available.

Keyword

Teriflunomide; Multiple sclerosis; Suboptimal response

MeSH Terms

Humans
Interferon-beta*
Interferons*
Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting*
Interferon-beta
Interferons
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr